Transient Growth Factor Delivery Sustains Regenerated Axons after Spinal Cord Injury
Open Access
- 26 September 2007
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 27 (39) , 10535-10545
- https://doi.org/10.1523/jneurosci.1903-07.2007
Abstract
Growth factors influence the topography of axonal projections during nervous system development and facilitate axonal sprouting and regeneration after injury in the adult. However, in the absence of target reinnervation and reestablishment of synaptic activity, we hypothesized that continuing delivery of neurotrophins would be required to sustain regenerating axons for prolonged times points after neurotrophin-induced axon growth after spinal cord injury (SCI) in the adult. Using tetracycline-inducible expression of brain-derived neurotrophic factor by genetically modified fibroblasts, we were able to extensively and significantly turn growth factor expression “on” or “off”in vitroandin vivowithin sites of SCI. Notably, we find that transient growth factor delivery is sufficient to sustain regenerated axons for prolonged time periods within spinal cord lesion sites. Immunohistochemical analysis demonstrated an absence of neuronal targets or synapses within transient growth factor expressing grafts but the persistent presence of Schwann cells. Thus, the adult CNS appears capable of sustaining axons that have extended after transient growth factor delivery, an effect potentially attributable to the persistence of Schwann cells in lesion/graft sites.Keywords
This publication has 48 references indexed in Scilit:
- Axonal responses to cellularly delivered NT-4/5 after spinal cord injuryMolecular and Cellular Neuroscience, 2004
- Brain‐derived neurotrophic factor is expressed in a gradient in the superior colliculus during development of the retinocollicular projectionEuropean Journal of Neuroscience, 2004
- Neurotrophin-3 Is Required for Appropriate Establishment of Thalamocortical ConnectionsNeuron, 2002
- Modulation of neuronal survival and axonal growth in vivo by tetracycline-regulated neurotrophin expressionGene Therapy, 2001
- Chronically Injured Supraspinal Neurons Exhibit Only Modest Axonal Dieback in Response to a Cervical Hemisection LesionExperimental Neurology, 2001
- Neurite outgrowth can be modulated in vitro using a tetracycline-repressible gene therapy vector expressing human nerve growth factorJournal of Neuroscience Research, 2000
- Treatment of the Chronically Injured Spinal Cord with Neurotrophic Factors Can Promote Axonal Regeneration from Supraspinal NeuronsExperimental Neurology, 1997
- The Molecular Biology of Axon GuidanceScience, 1996
- Nerve Growth Factor Delivery by Gene Transfer Induces Differential Outgrowth of Sensory, Motor, and Noradrenergic Neurites after Adult Spinal Cord InjuryExperimental Neurology, 1996
- Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve.The Journal of cell biology, 1993